FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604481947> ?p ?o ?g. }

• W2604481947 endingPage "513" @default.
• W2604481947 startingPage "507" @default.
• W2604481947 abstract "Background: Possible targeted therapies for metastatic triple negative breast cancer (TNBC) include cytotoxic chemotherapy that causes interstrand breaks (platinum-based drugs). The excision repair cross-complementation 1 (ERCC1) enzyme plays an essential role in the nucleotide excision repair pathway, removing platinum-induced DNA adducts and contributing to cisplatin resistance. Detecting ERCC1 overexpression is important in considering treatment options for metastatic TNBC, including individualized approaches to therapy, and may facilitate improved responses or reduction of unnecessary toxicity. We hypothesized that assigning cisplatin based on pretreatment ERCC1 expression would improve response and survival. This study was conducted to assess the impact of ERCC1 expression on PFS, OS and response rates in metastatic triple negative breast cancer patients treated with platinum-based chemotherapy. Methods: From June 2012 to November 2013, 52 metastatic triple negative breast cancer patients were enrolled. ERCC1 protein expression was detected from pretreatment biopsies by Immunohistochemistry. All patients received cisplatin plus paclitaxel. The primary end point was the impact of ERCC1 expression on PFS and OS. Results: 34 patients (65.4%) showed positive ERCC1 expression while 18 (34.6%) proved negative. Positive ERCC1 expression was associated with short PFS (median, 5 months vs. 7 months; P = 0.043), short OS (median, 9 months vs. 11 months; P = 0.033) and poor response to cisplatin based chemotherapy (P = 0.046). Conclusions: This prospective study further validated ERCC1 as a reliable biomarker for customized chemotherapy in metastatic triple negative breast cancer patients. High expression of ERCC1 was thereby fond to be significantly associated with poor outcome in patients treated with platinum based chemotherapy." @default.
• W2604481947 created "2017-04-14" @default.
• W2604481947 creator A5083764019 @default.
• W2604481947 creator A5087562701 @default.
• W2604481947 date "2017-02-01" @default.
• W2604481947 modified "2023-09-29" @default.
• W2604481947 title "ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy" @default.
• W2604481947 cites W179803722 @default.
• W2604481947 cites W1802949207 @default.
• W2604481947 cites W1903272704 @default.
• W2604481947 cites W1963517973 @default.
• W2604481947 cites W1969346276 @default.
• W2604481947 cites W1974753377 @default.
• W2604481947 cites W1974834222 @default.
• W2604481947 cites W1986383075 @default.
• W2604481947 cites W2004629780 @default.
• W2604481947 cites W2004718750 @default.
• W2604481947 cites W2013968185 @default.
• W2604481947 cites W2023826235 @default.
• W2604481947 cites W2044702943 @default.
• W2604481947 cites W2081418395 @default.
• W2604481947 cites W2084415574 @default.
• W2604481947 cites W2093736774 @default.
• W2604481947 cites W2098645377 @default.
• W2604481947 cites W2110578052 @default.
• W2604481947 cites W2111766542 @default.
• W2604481947 cites W2113467423 @default.
• W2604481947 cites W2125094267 @default.
• W2604481947 cites W2128463799 @default.
• W2604481947 cites W2130177169 @default.
• W2604481947 cites W2132893003 @default.
• W2604481947 cites W2133712354 @default.
• W2604481947 cites W2139248078 @default.
• W2604481947 cites W2142486051 @default.
• W2604481947 cites W2156214772 @default.
• W2604481947 cites W2157978805 @default.
• W2604481947 cites W2162505010 @default.
• W2604481947 cites W2170454539 @default.
• W2604481947 cites W2170529005 @default.
• W2604481947 cites W2170602872 @default.
• W2604481947 doi "https://doi.org/10.22034/apjcp.2017.18.2.507" @default.
• W2604481947 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5454751" @default.
• W2604481947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28345838" @default.
• W2604481947 hasPublicationYear "2017" @default.
• W2604481947 type Work @default.
• W2604481947 sameAs 2604481947 @default.
• W2604481947 citedByCount "11" @default.
• W2604481947 countsByYear W26044819472018 @default.
• W2604481947 countsByYear W26044819472019 @default.
• W2604481947 countsByYear W26044819472020 @default.
• W2604481947 countsByYear W26044819472021 @default.
• W2604481947 countsByYear W26044819472022 @default.
• W2604481947 countsByYear W26044819472023 @default.
• W2604481947 crossrefType "journal-article" @default.
• W2604481947 hasAuthorship W2604481947A5083764019 @default.
• W2604481947 hasAuthorship W2604481947A5087562701 @default.
• W2604481947 hasConcept C104317684 @default.
• W2604481947 hasConcept C104451858 @default.
• W2604481947 hasConcept C121608353 @default.
• W2604481947 hasConcept C126322002 @default.
• W2604481947 hasConcept C134935766 @default.
• W2604481947 hasConcept C143998085 @default.
• W2604481947 hasConcept C2775930923 @default.
• W2604481947 hasConcept C2776694085 @default.
• W2604481947 hasConcept C2777292972 @default.
• W2604481947 hasConcept C2778239845 @default.
• W2604481947 hasConcept C2779309665 @default.
• W2604481947 hasConcept C2780110267 @default.
• W2604481947 hasConcept C2780521871 @default.
• W2604481947 hasConcept C2781197716 @default.
• W2604481947 hasConcept C530470458 @default.
• W2604481947 hasConcept C55493867 @default.
• W2604481947 hasConcept C71924100 @default.
• W2604481947 hasConcept C86803240 @default.
• W2604481947 hasConceptScore W2604481947C104317684 @default.
• W2604481947 hasConceptScore W2604481947C104451858 @default.
• W2604481947 hasConceptScore W2604481947C121608353 @default.
• W2604481947 hasConceptScore W2604481947C126322002 @default.
• W2604481947 hasConceptScore W2604481947C134935766 @default.
• W2604481947 hasConceptScore W2604481947C143998085 @default.
• W2604481947 hasConceptScore W2604481947C2775930923 @default.
• W2604481947 hasConceptScore W2604481947C2776694085 @default.
• W2604481947 hasConceptScore W2604481947C2777292972 @default.
• W2604481947 hasConceptScore W2604481947C2778239845 @default.
• W2604481947 hasConceptScore W2604481947C2779309665 @default.
• W2604481947 hasConceptScore W2604481947C2780110267 @default.
• W2604481947 hasConceptScore W2604481947C2780521871 @default.
• W2604481947 hasConceptScore W2604481947C2781197716 @default.
• W2604481947 hasConceptScore W2604481947C530470458 @default.
• W2604481947 hasConceptScore W2604481947C55493867 @default.
• W2604481947 hasConceptScore W2604481947C71924100 @default.
• W2604481947 hasConceptScore W2604481947C86803240 @default.
• W2604481947 hasIssue "2" @default.
• W2604481947 hasLocation W26044819471 @default.
• W2604481947 hasOpenAccess W2604481947 @default.
• W2604481947 hasPrimaryLocation W26044819471 @default.
• W2604481947 hasRelatedWork W1974028357 @default.
• W2604481947 hasRelatedWork W1974753377 @default.

• next